Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesClinical/Medical PolicyLucet ABA Coverage Prior Auth Update | OpenPayer
    Ask Trek AI about this page
    CurrentlucetPolicy 20.5.006

    Applied Behavior Analysis for the Treatment of Down Syndrome

    Customize your policy alerts

    Sign up for lucet Policy 20.5.006 alerts

    Get alerted when Policy 20.5.006 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Governs medical necessity and authorization requirements for Applied Behavior Analysis (ABA) services for Lucet members diagnosed with Down syndrome (without comorbid ASD) and applies to providers and Lucet workforce managing ABA benefits for plan year 2024.

    Policy Summary
    Payerlucet
    PolicyApplied Behavior Analysis for the Treatment of Down Syndrome
    Policy CodePolicy 20.5.006
    Change TypeNo material change
    Effective DateJan 17, 2024
    Next Review DateSep 23, 2024
    Key ActionObtain prior authorization demonstrating diagnostic confirmation, required baseline assessments, approved treatment goals, and a plan for caregiver training and generalization.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    Down syndromeprimary diagnosis
    11initial criteria items
    2review refs
    Floridastate mandate

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Coverage Criteria for ABA Services (Down syndrome)

    ABA Pre-treatment Assessment

    Covered when ALL of the following are met for pre-treatment assessment

    Pre-treatment assessment: 1. The member has a diagnosis of Down Syndrome (without a comorbid diagnosis of ASD) from a clinician who is licensed and qualified to make such a diagnosis and confirmed by genetic testing.
    Pre-treatment assessment: 2. Hours requested are not more than what is required to complete the pretreatment assessment.
    Pre-treatment assessment: 3. All assessment services are provided in a manner consistent with the Lucet Provider Manual, the Behavior Analysis Certification Board's Ethics Code for Behavior Analysts or relevant ethics code, generally accepted standards of care, and applicable state laws.

    Initial ABA Treatment Authorization

    Covered when ALL of the following are met for initial ABA treatment authorization

    Initial ABA authorization 1-3: 1. Diagnostic Criteria as set forth in the pre-treatment assessment are met. 2. Documentation of psychological assessment, including adaptive behavior testing and cognitive evaluation to define baseline functioning, accompanied by a formal report detailing scores and results. 3. Baseline data completed prior to or scheduled within 90 days of the assessment and no older than specified timeframes: (a) developmental and cognitive evaluation; (b) adaptive behavior assessment completed within 6 months of start date of treatment; (c) neurological evaluation as part of a comprehensive physical examination; (d) information required by state law.
    Initial ABA authorization 4-9: 4. Approved treatment goals and clinical documentation focused on active symptoms, substantial deficits that inhibit daily functioning, and clinically significant aberrant behaviors requiring the expertise of a Behavior Analyst, including a plan for stimulus and response generalization. 5. ABA treatment is not designed to attain academic performance. 6. ABA treatment is not a substitute for psychotherapy, occupational therapy, or other medical or behavioral health services. 7. Detailed, individualized coordination of care, safety planning, and discharge planning are conducted on an ongoing basis. 8. For comprehensive treatment, services are designed to reduce the developmental gap; OR for focused treatment, services target reduction of burden from selected targeted symptoms and increase appropriate alternative behaviors. 9. Treatment is provided in the setting and intensity appropriate for the member's clinical needs, determined by where target behaviors are occurring and where treatment is likely to impact those behaviors.
    Initial ABA authorization 10-11: 10. Treatment provided consistent with the Lucet Provider Manual, the Behavior Analysis Certification Board's Ethics Code for Behavior Analysts or relevant ethics code, generally accepted standards of care, and applicable state laws; in the absence of a state law, line therapy services are provided by an RBT, BCaBA, or Master/Doctoral level BCBA. 11. Treatment plan must include a plan to support generalization of skills across stimuli, contexts, and individuals via caregiver training or an appropriate alternative; provider must demonstrate transfer of instructional control to caregivers and identify an alternate plan (including post-discharge) if caregiver involvement is not successful.

    Continued ABA Treatment Authorization

    Covered when ALL of the following are met for continued ABA treatment

    Continued ABA authorization: 1. Criteria 1-11 in the Initial ABA Treatment Authorization Request are met. 2. Provider demonstrates clinical or social benefit and ongoing need by documenting: (a) clinical or social benefit to the child from treatment; (b) identification of new or continuing treatment goals; and (c) development of a new or continuing treatment plan based on progress evidenced by the member's behavioral changes and increased skill acquisition.

    Comorbid diagnoses of Down syndrome and Autism Spectrum Disorder (ASD) are managed under a separate policy: 20.5.005 Applied Behavior Analysis for the Treatment of Autism Spectrum Disorder. This policy (20.5.006) applies to ABA coverage decisions for members with Down syndrome without comorbid ASD. Additionally, ABA is not intended to achieve academic performance and other non‑ABA treatments or educational interventions fall outside the scope of this policy.

    Requests for ABA services that do not include the required diagnostic confirmation, baseline assessments, or treatment focus will not meet medical necessity. Specifically, documentation must satisfy initial authorization items including: a confirmed diagnosis per the pre‑treatment assessment, a psychological assessment with adaptive behavior testing and cognitive evaluation (with formal reports), baseline data completed prior to or scheduled within 90 days and not older than specified timeframes (e.g., adaptive behavior assessment within 6 months of treatment start), and treatment goals focused on active symptoms and substantial deficits requiring the expertise of a Behavior Analyst. Services that are substitutes for psychotherapy, occupational therapy, or other medical/behavioral services are also not appropriate under this policy.

    Provider Requirements and Authorization Actions

    Prior Authorization

    Prior Authorization Required

    Prior authorization is required for pre-treatment assessment, initial ABA, and continued ABA. Requests must demonstrate a confirmed diagnosis (including genetic confirmation for Down Syndrome when specified), medically necessary hours not exceeding documented need, and alignment with the documentation and assessment requirements described below.

    • Applies to pre-treatment assessment, initial treatment, and continued treatment requests
    • Hours requested must be supported by documented need and not exceed what is required to complete the service
    • Diagnosis must be documented and, for Down Syndrome without comorbid ASD, confirmed by genetic testing
    Note

    Provider Actions — Coordinate Treatment with Other Services

    Treatment must be coordinated with other services and is not a substitute for psychotherapy, occupational therapy, or other medical or behavioral health services. Providers must document ongoing coordination of care, safety planning, and discharge planning, and ensure that ABA is delivered in the appropriate setting and intensity for the member's clinical needs.

    • ABA is not a substitute for psychotherapy, OT, or other medical/behavioral services
    • Detailed, individualized coordination of care, safety planning, and discharge planning are required and must be documented
    • Treatment setting and intensity must be appropriate to where target behaviors occur and where treatment will impact those behaviors
    Documentation Required

    Provider Actions — Documentation and Baseline Assessment Required

    Requests must include comprehensive psychological assessment documentation: adaptive behavior testing, cognitive evaluation, formal reports with scores, and baseline data. Baseline data must be completed prior to or scheduled within 90 days of the assessment and no older than five years (with some assessments required within shorter windows as noted).

    • Psychological assessment including adaptive behavior testing and cognitive evaluation with formal reports and score details
    • Baseline data completed prior to or scheduled within 90 days of the assessment and not older than 5 years
    • Required baseline elements include developmental/cognitive evaluation, adaptive behavior assessment within 6 months of treatment start, neurological evaluation as part of a comprehensive physical, and any information required by state law
    Denial Risk

    Provider Actions — Denial Risks

    Requests may be denied if the member lacks a documented diagnosis (including required genetic confirmation for Down Syndrome without comorbid ASD) or if the hours requested exceed the documented clinical need.

    • Denial risk when diagnosis is not documented or genetic confirmation is absent where required
    • Denial risk when requested hours exceed what is supported by assessments, baseline data, and treatment plan

    Key Definitions

    inv-11: Behavior Intervention Plan — definition
    DefinitionBehavior Intervention Plan: A written document that describes a pattern of aberrant behavior, the environmental conditions that contribute to that pattern, the supports and interventions that will reduce the behavior, and the skills that will be taught as an alternative to the behavior.
    Key componentsDescribes aberrant behavior patterns, contributing environmental conditions, and alternative skill instruction.
    Interventions and supportsSpecifies supports and interventions intended to reduce target behaviors.
    Purpose/actionable itemPlan must document measurable replacement skills to be taught as alternatives to the behavior and strategies to reduce occurrences.
    Context of useUsed as the individualized roadmap for behavioral treatment and caregiver training within ABA services.
    inv-12: Functional Behavior Assessment (FBA) — definition
    DefinitionFunctional Behavior Assessment (FBA): Descriptive assessment procedures designed to identify environmental events that occur just before and just after occurrences of potential target behaviors and that may influence those behaviors.
    MethodsInformation may be gathered via caregiver interviews, caregiver-completed checklists/rating scales/questionnaires, and direct observation and recording of target behaviors in everyday situations.
    PurposeIdentify antecedents and consequences influencing target behaviors to inform intervention planning.
    DocumentationFBA findings should include observed antecedents/consequences, data from interviews and checklists, and recorded occurrences to support behavior intervention planning.
    inv-13: Generalization — definition
    DefinitionGeneralization: Skills acquired in one setting are applied to many contexts, stimuli, materials, people and/or settings to be practical, useful, and functional for the individual.
    Clinical importanceGeneralized behavior change requires systematic planning and must be a central part of every intervention and caregiver training strategy.
    OutcomeWhen the member accomplishes generalization, there is increased likelihood of completing tasks independently.
    ImplementationIntervention plans must include strategies to promote transfer across contexts, stimuli, people, and settings.
    inv-14: Mastery Criteria — definition
    DefinitionMastery Criteria: Objectively and quantitatively stated percentage, frequency or intensity and duration in which a member must display a skill/behavior to be considered an acquired skill/behavior, including generalization and maintenance.
    ComponentsShould specify measurable criteria such as percentage correct, frequency, intensity, or duration and include requirements for generalization and maintenance.
    Use in treatmentApplied to determine when a skill is considered acquired and to guide discharge or progression decisions.
    DocumentationMastery criteria must be recorded in treatment goals and linked to data demonstrating attainment, generalization, and maintenance over time.

    Background

    Down syndrome (also called Trisomy 21) is a chromosomal condition in which an individual has an extra copy of chromosome 21. This additional genetic material alters development of the body and brain and commonly causes developmental and cognitive delays, including delayed language development and general reductions in intellectual functioning (often in the mildly‑to‑moderately low range). Clinical presentation and physical features vary substantially between individuals; ABA services under this policy are intended to address behavioral and functional deficits associated with Down syndrome rather than provide non‑behavioral or educational interventions.

    Policy Summary
    Payerlucet
    PolicyApplied Behavior Analysis for the Treatment of Down Syndrome
    Policy CodePolicy 20.5.006
    Change TypeNo material change
    Effective DateJan 17, 2024
    Next Review DateSep 23, 2024
    Key ActionObtain prior authorization demonstrating diagnostic confirmation, required baseline assessments, approved treatment goals, and a plan for caregiver training and generalization.
    SourceLink
    On This Page
    Coverage Criteria for ABA Services (Down syndrome)Provider Requirements and Authorization ActionsKey DefinitionsBackground